Chicken is a common protein source in pet foods and is concurrently listed among food allergens. Commercial over-the-counter (OTC) diets with an alternative animal protein source are considered suitable for dietary elimination trials by pet owners.
| INTRODUC TI ON
The conformity of the product description provided on the label with the actual composition is essential in both the human food market and the animal feed sector. To comply with the existing EU legislation, manufacturers must indicate on the label either all ingredients or categories, in a transparent, consistent, coherent and understandable manner (Commission Regulation EC 767/2009 ).
Recently, dog foods potentially useful in diagnosing adverse food reactions (AFR) have gained a significant market position (Ricci et al., 2013) . The interest of pet owners to use commercial over-thecounter (OTC) diets for dietary trials rather than veterinary prescribed products has increased because of cost and convenience (Raditic, Remillard, & Tater, 2011; Willis-Mahn, Remillard, & Tater, 2014) . However, the confusion over marketing can make informed diet choices challenging (Johnson, Heinze, Linder, & Freeman, 2015) For example, the use of the popular term "hypoallergenic," referring to products suitable for AFR diagnosis, is considered not entirely correct because of the enhanced complexity of pet foods (Ricci, Berlanda, Tenti, & Bailoni, 2009; Verlinden, Hesta, Millet, & Janssens, 2006) .
Further, pet owners are prone to assume that, if specific proteins or isolates are absent in the product ingredient list, then it does not contain these, and therefore, the diet is suitable for an elimination trial (Raditic et al., 2011) .
However, as previously reported, the detection of traces of undeclared animal proteins in pet foods formulated as limited antigen diets is unacceptable because of the risk of false diagnostic results (Ricci et al., 2013) .
The results of the identification of adverse animal or plant proteins in both veterinary and commercial OTC dog and cat foods have been reported before, showing that at least some brands of commercial dog foods have an ingredient list that does not conform to the actual contents of the pet food bag (Horvath-Ungerboeck, Widmann, & Handl, 2017; Parr & Remillard, 2014; Raditic et al., 2011; Ricci et al., 2013) .
Chicken was reported to be the most commonly undeclared animal protein-supplying ingredient among the mislabelled foods by Okuma and Hellberg (2015) ; however, a substantial proportion of products tested in different studies published on the subject contained all and only those protein ingredients that were listed on their labels (Case, 2016) .
Moreover, chicken is listed among the allergens most frequently contributing to cutaneous adverse food reactions in dogs (Mueller, Olivry, & Prélaud, 2016) . To facilitate a reliable detection of allergenic ingredients, two major protein-and DNA-based analytical methods are used (Prado et al., 2016) . However, in processed meat products, proteins are often degraded, denatured or damaged and protein-based methods (e.g., enzyme-linked immunosorbent assay [ELISA] ) are considered inappropriate for species authentication (Hou et al., 2015) . Hsieh, Shih, Wei, Vickroy, and Chou (2016) revealed that ELISA, regarded as the most popular screening method, was unable to completely identify the presence of animal by-products as compared to a polymerase chain reaction (PCR) in commercial canned canine foods. More recently, Perestam, Fujisaki, Nava, and Hellberg (2017) found that real-time PCR was a more reliable and less expensive method to perform than the ELISA protocol. this method is considered a helpful tool to discriminate between a simple contamination episode and an intentional food fraud (Prandi et al., 2016) .
Therefore, the objective of this study was to assess using both qualitative and quantitative methods, the absence or presence of chicken DNA in OTC dry dog foods.
| MATERIAL S AND ME THODS

| Samples and sample preparation
In all, 10 diets of different brands, with marketing characteristics consistent with the description of OTC product given in the literature (Johnson et al., 2015; Raditic et al., 2011; Willis-Mahn et al., 2014) 
| DNA identification
A qualitative analysis was performed on Veriti Thermal Cycler (Applied Biosystems, Foster City, CA, USA) according to the PCR method proposed by Natonek-Wiśniewska, Krzyścin, and Piestrzyńska-Kajtoch (2013), using dried chicken meat as a positive control (PTC) and water as a negative control (NTC). In the quantitative analysis, the qPCR technology was used, described in detail in Natonek-Wiśniewska and Krzyścin (2016) .
In the PCR analysis, the following starters were used: 
| Construction of standard curve and validation procedure
A set of serial dilutions (100%, 10%, 1%, 0.1%, 0.06%, 0.04%, 0.02% and 0.01%, w/w) of the DNA extract (75 ng/PCR) obtained from dried chicken meat was used for the construction of the standard curve in the qPCR analysis.
The in-house validation procedure was performed using a set of thermally processed (cooked) blind meat mixtures containing 50.0%, 25.0%, 12.5%, 6.25% and 3.25% (w/w) of commercially available chicken meat spiked in pork, as described by Amaral, Santos, Oliveira, and Mafra (2017).
| RE SULTS
| DNA isolation
The isolation yield was between 99.5 and 314 ng of DNA/μl of isolate with an A 260/280 ratio of 1.82-1.92.
| Qualitative assay
The results of the DNA amplification in the products from batch A are presented in Figure 1 . Wells from 1 to 10 refer to the diets evaluated F I G U R E 2 Calibration curves for evaluated diets. %, concentration of chicken DNA; C T , threshold cycle; A, B and C, batches 
TA B L E 2 Results of blind mixtures assay for qPCR validation
in the study, whereas those numbered from 11 to 20 are PCD. The specificity of the method used was clearly observed. For products with no apparently dubious ingredients listed (1-3), a distinct band was found for product 1 suggesting the presence of chicken DNA.
In the formula of the following products (except 7), the primary potentially controversial ingredient was animal fat.
| Quantitative assay
Standard curves were highly effective for the chicken DNA quantification in the examined products. The qPCR reactions showed a high specificity with a γ intercept of 22 and a regression coefficient (R 2 ) of 1 (StepOnePlus 2.3).
The range of the slope observed for the examined batches of dog foods (from −3.22 to −3.43) was related to the amplification efficiency of more than 95.66% (Figures 2 and 3 ).
For the in-house validation of the real-time PCR method used, different characteristics commonly considered the quality benchmarks in the verification of the laboratory results were assessed (Bustin et al., 2009) . Table 2 shows the results of the estimated chicken DNA content according to the calibration curves created for the study. The coefficients of variation for both samples (A and B) revealed the high accuracy of the assays (<25%). The calculated bias within ±25% of the actual values denoted the trueness of the measurements as well as the applicability of the matrix used for the construction of the standard curves (Svec, Tichopad, Novosadova, Pfaffl, & Kubista, 2015) .
In all but one of the tested products, measurable amounts of the chicken DNA were detected in at least two of the three samples, collected from different batches (Table 3) . A majority of the results
showed that the concentration of the chicken DNA was <1% (five products).
Slightly higher amounts (range: 2%-4%) were revealed in three subsequent dog foods. In the case of product number 3, the chicken DNA could not be detected within the LOD (0.1%) irrespective of the batch.
The highest content of the chicken DNA (approx. 11%) was found for product 1, with no potentially misleading ingredients declared on the label. For this diet, each sampled batch contained a substantial amount of the adverse protein.
Observable differences in the chicken DNA concentrations were found in different batches of the same product.
| D ISCUSS I ON
Authenticity of product labelling is an essential issue in the avoidance of safety risks caused by the introduction of particular ingredients potentially challenging to animal health. In spite of the existing mandatory traceability requirements for pet foods, labels were previously reported to provide insufficient information about the sources of various nutrients in the product (Johnson et al., 2015; Pegels, González, García, & Martín, 2014) . In the current study, detectable amounts of the chicken DNA were revealed in various batches for nine of the ten dry OTC dog foods, having no label declaration of the chicken-derived components used as the main source of animal protein. However, some of them contained feed materials that could potentially contribute to the positive results of the qPCR analysis towards the chicken DNA. These included animal fats (listed as animal fat, chicken fat or poultry fat), liver hydrolysates, natural flavours or digest (Parr & Remillard, 2014) . Note that, according to the current legislation, feed materials of an avian origin do not require species identification when intended for pet animals (Veys, Berben, Dardenne, & Baeten, 2012) . Indeed, chicken and poultry fat are the two types of animal fat most commonly included in pet foods (Case, Daristotle, Hayek, & Raasch, 2011) .
Interestingly, the protein content in animal fats (including chicken fat) has been previously reported to be a limiting factor in biodiesel production (Banković-Ilić, Stojković, Stamenković, Veljkovic, & Hung, 2014). Alptekin, Canakci, and Sanli (2014) explained the high content of sulphur in the chicken fat used as feedstock for biodiesel production, with the presence of sulphur-containing proteins, mostly keratin.
In the current study, we detected small but measurable chicken DNA amounts in OTC products, labelled using a generic name for animal fats. We speculated that chicken fat of poor quality, most likely contaminated with proteins, was used in the production process. Therefore, the presence of undeclared material in these dog foods should not be seen as a violation of regulations but as reasonably unavoidable under good processing practices (Willis-Mahn et al., 2014) .
In the case of product number 1, the justification of the relatively high amounts of undeclared DNA revealed in all of the examined batches, as a result of an accidental cross-contamination, is unexemplified.
| CON CLUS ION
The PCR analysis of the samples collected from multiple batches of a product is effective for better characterization and prevention of potential feed safety concerns. Manufacturers should practice stringent quality control to minimize the practically feasible significant cross-contact of ingredients to the best possible extent, to support consumer confidence when selecting a diet for their pets.
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